$LIV SAMARITAN PHARMACEUTICALS INC Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in SAMARITAN PHARMACEUTICALS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in SAMARITAN PHARMACEUTICALS INC. Insider overview, share value development, latest insider transactions and email notifications about new events in SAMARITAN PHARMACEUTICALS INC for free.
IRS Number: 880431538
Industry: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
Trading Symbol: LIV
Company Address: 101 CONVENTION CENTER DRIVE SUITE 310 LAS VEGAS 89109
Former name: STEROIDOGENESIS INHIBITORS INTERNATIONAL INC, date of change: 1998-10-01
Prev close: $0.00
Average Daily Volume: 0
Days Low: $0.00
Year Low: $0.00
Year High: $0.00
SAMARITAN PHARMACEUTICALS INC Latest Insider Transactions
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 15 2008 | LIV | SAMARITAN PHARMACE ... | BOYLE EUGENE | Chief Financial Off ... | Grant | A | 0.20 | 435,000 | 86,130 | 435,000 | 0 to 435 K |
| Sep 15 2008 | LIV | SAMARITAN PHARMACE ... | BOYLE EUGENE | Chief Financial Off ... | Sell | D | 0.20 | 435,000 | 86,130 | 674,207 | 1.1 M to 674.2 K (-39.22 %) |
| Sep 15 2008 | LIV | SAMARITAN PHARMACE ... | GREESON JANET | Chief Executive Off ... | Option Exercise | A | 0.19 | 57,895 | 11,000 | 57,895 | |
| Sep 15 2008 | LIV | SAMARITAN PHARMACE ... | GREESON JANET | Chief Executive Off ... | Grant | A | 0.20 | 1,000,000 | 197,000 | 1,000,000 | 0 to 1000 K |
| Sep 15 2008 | LIV | SAMARITAN PHARMACE ... | GREESON JANET | Chief Executive Off ... | Sell | D | 0.20 | 1,000,000 | 197,000 | 833,356 | 1.8 M to 833.4 K (-54.54 %) |
| Aug 11 2008 | LIV | SAMARITAN PHARMACE ... | GREESON JANET | Chief Executive Off ... | Option Exercise | A | 0.25 | 60,000 | 15,000 | 60,000 | |
| Jul 29 2008 | LIV | SAMARITAN PHARMACE ... | Weaver George A Jr | Grant | A | 0.20 | 112,465 | 22,493 | 112,465 | 0 to 112.5 K | |
| Jul 29 2008 | LIV | SAMARITAN PHARMACE ... | Lang Thomas Arnold | Chief Drug Developm ... | Grant | A | 0.20 | 162,239 | 32,448 | 162,239 | 0 to 162.2 K |
| Jul 29 2008 | LIV | SAMARITAN PHARMACE ... | BOYLE EUGENE | Chief Financial Off ... | Option Exercise | A | 0.25 | 120,000 | 30,000 | 120,000 | |
| Jul 29 2008 | LIV | SAMARITAN PHARMACE ... | BOYLE EUGENE | Chief Financial Off ... | Grant | A | 0.20 | 496,512 | 99,302 | 1,109,207 | 612.7 K to 1.1 M (+81.04 %) |
| Jul 29 2008 | LIV | SAMARITAN PHARMACE ... | GREESON JANET | Chief Executive Off ... | Grant | A | 0.20 | 827,646 | 165,529 | 1,833,356 | 1 M to 1.8 M (+82.29 %) |
| Apr 04 2008 | LIV | SAMARITAN PHARMACE ... | GREESON JANET | Chief Executive Off ... | Option Exercise | A | 0.33 | 1,060,606 | 350,000 | 1,060,606 | |
| Jan 08 2008 | LIV | SAMARITAN PHARMACE ... | BOYLE EUGENE | Chief Financial Off ... | Grant | A | 0.35 | 529,361 | 185,276 | 612,695 | 83.3 K to 612.7 K (+635.23 %) |
| Jan 08 2008 | LIV | SAMARITAN PHARMACE ... | BOYLE EUGENE | Chief Financial Off ... | Sell | D | 0.35 | 529,361 | 185,276 | 1,683,065 | 2.2 M to 1.7 M (-23.93 %) |
| Jan 08 2008 | LIV | SAMARITAN PHARMACE ... | GREESON JANET | Chief Executive Off ... | Grant | A | 0.35 | 672,376 | 235,332 | 839,043 | 166.7 K to 839 K (+403.42 %) |
View all SAMARITAN PHARMACEUTICALS INC insider transactions.